Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Sands during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Protagonist Therapeutics, Inc.
- American College of Gastroenterology
- Janssen Scientific Affairs, LLC
- Boehringer Ingelheim Corporation
- Target RWE
- Eli Lilly and Company
- Connect Biopharm
- Adiso Therapeutics USA
- Synlogic
- Alimentiv
- AstraZeneca
- Arena Pharmaceuticals, Inc.
- Amgen Inc.
- Galapagos
- Bristol-Myers Squibb
- HMP Global
- Janssen Pharmaceutica NV
- Morphic Therapeutic
- Prometheus Biosciences
- Immunyx Pharma
- Surrozen
- GossamerBio
- Takeda (China) International Trading Co., Ltd.
- Index Pharmaceuticals
- Genentech, Inc.
- WebMD
- MJH Healthcare Holdings
- Artizan Biosciences
- Clinical Care Options, LLC (CCO)
- TLL Pharmaceutical
- Immunic
- Progenity, Inc.
- Celltrion Healthcare Co. Ltd.
- Applied Molecular Transport (AMT)
- Ferring Pharmaceuticals
- Vindico Medical Education
- Janssen Research & Development, LLC
- Pfizer Australia Holdings PTY Limited
- Cytoki Pharma
- Fresenius Kabi
- Integritas Communications, LLC
- Takeda Pharmaceutical Company Limited
- Prometheus Laboratories
- Merck Sharp & Dohme Corp
- AnaptysBio, Inc
- Abivax
- Focus Medical Communications
- Imhotex
- AbbVie Inc.
- MRM Health NV
- EcoR1 Capital
- Microbiotica Limited
- Janssen Biotech, Inc. (formerly Centocor Ortho Biotech Inc.)
- American Gastroenterological Association (AGA)
- Janssen-Cilag PTY, Ltd.
- Johnson & Johnson Services, Inc.
- Ventyx Biosciences
- Pfizer Inc., U.S. Pharmaceuticals Group
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Sands during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Protagonist Therapeutics, Inc.
- American College of Gastroenterology
- Janssen Scientific Affairs, LLC
- Boehringer Ingelheim Corporation
- Target RWE
- Eli Lilly and Company
- Connect Biopharm
- Adiso Therapeutics USA
- Synlogic
- Alimentiv
- AstraZeneca
- Arena Pharmaceuticals, Inc.
- Amgen Inc.
- Galapagos
- Bristol-Myers Squibb
- HMP Global
- Janssen Pharmaceutica NV
- Morphic Therapeutic
- Prometheus Biosciences
- Immunyx Pharma
- Surrozen
- GossamerBio
- Takeda (China) International Trading Co., Ltd.
- Index Pharmaceuticals
- Genentech, Inc.
- WebMD
- MJH Healthcare Holdings
- Artizan Biosciences
- Clinical Care Options, LLC (CCO)
- TLL Pharmaceutical
- Immunic
- Progenity, Inc.
- Celltrion Healthcare Co. Ltd.
- Applied Molecular Transport (AMT)
- Ferring Pharmaceuticals
- Vindico Medical Education
- Janssen Research & Development, LLC
- Pfizer Australia Holdings PTY Limited
- Cytoki Pharma
- Fresenius Kabi
- Integritas Communications, LLC
- Takeda Pharmaceutical Company Limited
- Prometheus Laboratories
- Merck Sharp & Dohme Corp
- AnaptysBio, Inc
- Abivax
- Focus Medical Communications
- Imhotex
- AbbVie Inc.
- MRM Health NV
- EcoR1 Capital
- Microbiotica Limited
- Janssen Biotech, Inc. (formerly Centocor Ortho Biotech Inc.)
- American Gastroenterological Association (AGA)
- Janssen-Cilag PTY, Ltd.
- Johnson & Johnson Services, Inc.
- Ventyx Biosciences
- Pfizer Inc., U.S. Pharmaceuticals Group
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.